HOLON, Israel, May 14, 2020 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY) (TASE: FORT), today announced its financial results for the first quarter ended March 31, 2020.
Summary Results for First Quarter 2020 (USD in millions, except per share data) |
||||||
GAAP |
Non-GAAP |
|||||
March 31, 2020 |
March 31, 2019 |
% Change |
March 31, 2020 |
March 31, 2019 |
% Change |
|
Revenue |
$90.5 |
$76.8 |
17.9% |
$90.5 |
$76.8 |
17.9% |
Gross Profit |
$36.3 |
$29.8 |
21.7% |
$39.8 |
$33.1 |
20.2% |
Gross Margin |
40.1% |
38.8% |
130 bps |
44.0% |
43.1% |
90 bps |
Operating Income |
$10.3 |
$8.1 |
27.3% |
$14.6 |
$11.8 |
24.4% |
Operating Margin |
11.4% |
10.5% |
90 bps |
16.1% |
15.3% |
80 bps |
Net Income (*) |
$6.8 |
$5.2 |
32.3% |
$10.4 |
$8.4 |
24.1% |
Diluted EPS |
$0.13 |
$0.10 |
30% |
$0.20 |
$0.17 |
17.6% |
(*) Attributable to Sapiens' shareholders |
"Sapiens' first-quarter performance reflects our continued focus on supporting our existing customers and closing new business," said Roni Al-Dor, president and CEO, Sapiens. "On a non-GAAP basis, we reported 17.9% revenue growth and increased operating margins by 80 basis points to 16.1%, with both P&C and L&A contributing to growth in the quarter."
"In March, we responded to the COVID-19 global outbreak per country, controlling expenses where appropriate, while maintaining productivity. I'm incredibly proud of my teams' accomplishments in this unique and challenging environment, and impressed by our customers' rapid shift to remote work, while they remained committed to their customers and their own digital transformation projects. As a result, Sapiens maintained momentum through the quarter," said Al-Dor.
Continued Al-Dor: "Across all our product lines, we see a growing demand for managed services, which is a testament to our delivery model – it allows carriers to focus on running their business. The current business disruption highlights the need for legacy insurance companies to migrate their platforms and increase their relevancy with more digital solutions. Our recent acquisition in Germany, sum.cumo, expands our digital offerings, helping us become even more competitive. While there continues to be uncertainty resulting from COVID-19, we remain focused on executing our long-term strategy. I am confident that as the global economy recovers, Sapiens will emerge stronger and well- positioned for continued growth."
"Strong demand for our digital products, combined with high recurring revenue and a solid balance sheet, position us for success in this challenging environment. We've taken appropriate actions to provide the necessary flexibility for revenue growth and operating efficiency within the current circumstances. While our business remains strong, due to macro events there could be delays in closing new deals, which could slightly impact our revenue. Therefore, we are slightly revising our annual revenue guidance for 2020 to the range of $368 million to $377 million, as compared to our prior range of $377 million to $383 million. Overall, we changed the mid-point of the revenue guidance by 2.0%. Sapiens' guidance for annual operating margin remains unchanged at 16.0% to 16.5%," said Al-Dor.
"Furthermore, Sapiens remains committed to returning value to shareholders," concluded Al-Dor. "Despite the condition in the market, we announce a dividend of $0.14 per share – approximately $7 million – reflecting our continued confidence in our business and Sapiens' ability to generate cash."
The dividend will be paid on June 10, 2020 to Sapiens Shareholders of record as of May 27, 2020. The prospective dividend is subject to withholding tax at source, under the Israeli Tax law, at the rate of 25% of the dividend amount payable to each shareholders of record.
Quarterly Results Conference Call
Management will host a conference call and webcast on May 14, 2020 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.
Please call the following numbers (at least 10 minutes before the scheduled time) to participate:
North America (toll-free): + 1-888-407-2553; International: +972-3-918-0610; UK: 0-800-917-9141
The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations/
If you are unable to join live, a replay of the call will be accessible until May 23, 2020, as follows:
North America: 1-888-326-9310; International: +972-3-925-5925
A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.
Non-GAAP Financial Measures
This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.
Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, restructuring and cost reduction costs, tax adjustments related to non-GAAP adjustments, and acquisition-related costs, which pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.
Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.
To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.
Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.
The Company defines Adjusted EBITDA as net profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, financial and other expenses, and provision for income taxes. These amounts are often excluded by other companies to help investors understand the operational performance of their business.
The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.
The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back payments related to investment in the new campus in India, cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.
About Sapiens
Sapiens International Corporation empowers insurers to succeed in an evolving industry. The company offers digital software platforms, solutions and services for the property and casualty, life, pension and annuity, reinsurance, financial and compliance, workers' compensation and financial markets. With more than 35 years of experience delivering to over 450 organizations globally, Sapiens has a proven ability to satisfy customers' core, data and digital requirements. For more information: www.sapiens.com
Forward Looking Statement
Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.
These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2018, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES |
|||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||
U.S. dollars in thousands (except per share amounts) |
|||||
Three months ended |
|||||
March 31, |
|||||
2020 |
2019 |
||||
(unaudited) |
(unaudited) |
||||
Revenue |
90,534 |
76,787 |
|||
Cost of revenue |
54,270 |
46,980 |
|||
Gross profit |
36,264 |
29,807 |
|||
Operating expenses: |
|||||
Research and development, net |
10,526 |
8,777 |
|||
Selling, marketing, general and administrative |
15,460 |
12,953 |
|||
Total operating expenses |
25,986 |
21,730 |
|||
Operating income |
10,278 |
8,077 |
|||
Financial and other expenses, net |
1,487 |
1,054 |
|||
Taxes on income |
1,901 |
1,847 |
|||
Net income |
6,890 |
5,176 |
|||
Attributed to non-controlling interest |
70 |
21 |
|||
Net income attributable to Sapiens' shareholders |
6,820 |
5,155 |
|||
Basic earnings per share |
0.14 |
0.10 |
|||
Diluted earnings per share |
0.13 |
0.10 |
|||
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands) |
50,175 |
49,986 |
|||
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands) |
51,083 |
50,329 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES |
|||||
CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME |
|||||
U.S. dollars in thousands (except per share amounts) |
|||||
Three months ended |
|||||
March 31, |
|||||
2020 |
2019 |
||||
(unaudited) |
(unaudited) |
||||
Revenue |
90,534 |
76,787 |
|||
Cost of revenue |
50,743 |
43,683 |
|||
Gross profit |
39,791 |
33,104 |
|||
Operating expenses: |
|||||
Research and development, net |
11,963 |
10,169 |
|||
Selling, marketing, general and administrative |
13,214 |
11,185 |
|||
Total operating expenses |
25,177 |
21,354 |
|||
Operating income |
14,614 |
11,750 |
|||
Financial and other expenses, net |
1,487 |
1,054 |
|||
Taxes on income |
2,645 |
2,285 |
|||
Net income |
10,482 |
8,411 |
|||
Attributable to non-controlling interest |
70 |
21 |
|||
Net income attributable to Sapiens' shareholders |
10,412 |
8,390 |
|||
Basic earnings per share |
0.21 |
0.17 |
|||
Diluted earnings per share |
0.20 |
0.17 |
|||
Weighted average number of shares outstanding used |
50,175 |
49,986 |
|||
Weighted average number of shares outstanding used |
51,083 |
50,329 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES |
||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
||||
U.S. dollars in thousands (except per share amounts) |
||||
Three months ended |
||||
March 31, |
||||
2020 |
2019 |
|||
(unaudited) |
(unaudited) |
|||
GAAP gross profit |
36,264 |
29,807 |
||
Amortization of capitalized software |
1,496 |
1,341 |
||
Amortization of other intangible assets |
2,031 |
1,956 |
||
Non-GAAP gross profit |
39,791 |
33,104 |
||
GAAP operating income |
10,278 |
8,077 |
||
Gross profit adjustments |
3,527 |
3,297 |
||
Capitalization of software development |
(1,437) |
(1,392) |
||
Amortization of other intangible assets |
589 |
535 |
||
Stock-based compensation |
622 |
453 |
||
Acquisition-related costs *) |
1,035 |
780 |
||
Non-GAAP operating income |
14,614 |
11,750 |
||
GAAP net income attributable to Sapiens' shareholders |
6,820 |
5,155 |
||
Operating income adjustments |
4,336 |
3,673 |
||
Taxes on income |
(744) |
(438) |
||
Non-GAAP net income attributable to Sapiens' shareholders |
10,412 |
8,390 |
||
(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and |
Summary of NON-GAAP Financial Information |
|||||||||
U.S. dollars in thousands (except per share amounts) |
|||||||||
Q1 2020 |
Q4 2019 |
Q3 2019 |
Q2 2019 |
Q1 2019 |
|||||
Revenues |
90,534 |
86,715 |
82,643 |
79,529 |
76,787 |
||||
Gross profit |
39,791 |
38,402 |
36,712 |
34,794 |
33,104 |
||||
Operating income |
14,614 |
14,345 |
13,530 |
12,581 |
11,750 |
||||
Net income to Sapiens' shareholders |
10,412 |
10,553 |
10,412 |
9,541 |
8,390 |
||||
Adjusted EBITDA |
15,724 |
15,271 |
14,523 |
13,358 |
12,524 |
||||
Basic earnings per share |
0.21 |
0.21 |
0.21 |
0.19 |
0.17 |
||||
Diluted earnings per share |
0.20 |
0.21 |
0.21 |
0.19 |
0.17 |
Non-GAAP Revenues by Geographic Breakdown |
|||||||||
U.S. dollars in thousands |
|||||||||
Q1 2020 |
Q4 2019 |
Q3 2019 |
Q2 2019 |
Q1 2019 |
|||||
North America |
44,567 |
41,787 |
44,413 |
39,216 |
38,149 |
||||
Europe |
40,232 |
37,504 |
30,273 |
33,881 |
32,193 |
||||
Rest of the world |
5,735 |
7,424 |
7,957 |
6,432 |
6,445 |
||||
Total |
90,534 |
86,715 |
82,643 |
79,529 |
76,787 |
Adjusted Free Cash-Flow |
|||||||||
U.S. dollars in thousands |
|||||||||
Q1 2020 |
Q4 2019 |
Q3 2019 |
Q2 2019 |
Q1 2019 |
|||||
Cash-flow from operating activities |
5,759 |
21,429 |
18,671 |
15,507 |
10,550 |
||||
Increase in capitalized software development costs |
(1,437) |
(1,162) |
(1,541) |
(1,570) |
(1,392) |
||||
Capital expenditures |
(552) |
(2,456) |
(973) |
(1,079) |
(641) |
||||
Capital expenditures related to new campus in India |
- |
- |
(6,325) |
- |
- |
||||
Free cash-flow |
3,770 |
17,811 |
9,832 |
12,858 |
8,517 |
||||
Capital expenditures related to new campus in India |
- |
- |
6,325 |
- |
- |
||||
Cash payments attributed to acquisition-related costs(*) |
737 |
200 |
100 |
1,692 |
1,608 |
||||
Adjusted free cash-flow |
4,507 |
18,011 |
16,257 |
14,550 |
10,125 |
||||
(*) Included in cash-flow from operating activities |
|||||||||
(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets |
Adjusted EBITDA Calculation |
||||
U.S. dollars in thousands |
||||
Three months ended |
||||
March 31, |
||||
2020 |
2019 |
|||
(unaudited) |
(unaudited) |
|||
GAAP operating income |
10,278 |
8,077 |
||
Non-GAAP adjustments: |
||||
Amortization of capitalized software |
1,496 |
1,341 |
||
Amortization of other intangible assets |
2,620 |
2,491 |
||
Capitalization of software development |
(1,437) |
(1,392) |
||
Stock-based compensation |
622 |
453 |
||
Compensation related to acquisition and acquisition-related |
1,035 |
780 |
||
Non-GAAP operating income |
14,614 |
11,750 |
||
Depreciation |
1,110 |
773 |
||
Adjusted EBITDA |
15,724 |
12,523 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES |
|||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
U.S. dollars in thousands |
|||||
March 31, |
December 31, |
||||
2020 |
2019 |
||||
(unaudited) |
(unaudited) |
||||
ASSETS |
|||||
CURRENT ASSETS |
|||||
Cash and cash equivalents |
79,557 |
66,295 |
|||
Trade receivables, net and unbilled receivables |
59,958 |
50,221 |
|||
Investment in restricted deposit |
- |
22,890 |
|||
Other receivables and prepaid expenses |
8,105 |
7,817 |
|||
Total current assets |
147,620 |
147,223 |
|||
LONG-TERM ASSETS |
|||||
Property and equipment, net |
16,657 |
16,601 |
|||
Severance pay fund |
4,949 |
5,106 |
|||
Goodwill and intangible assets, net |
246,676 |
228,691 |
|||
Operating lease right-of-use assets |
45,872 |
49,539 |
|||
Other long-term assets |
6,549 |
5,261 |
|||
Total long-term assets |
320,703 |
305,198 |
|||
TOTAL ASSETS |
468,323 |
452,421 |
|||
LIABILITIES AND EQUITY |
|||||
CURRENT LIABILITIES |
|||||
Trade payables |
5,650 |
5,107 |
|||
Current maturities of Series B Debentures |
9,898 |
9,898 |
|||
Short-term bank loan |
20,000 |
- |
|||
Accrued expenses and other liabilities |
62,886 |
60,574 |
|||
Current maturities of operating lease liabilities |
7,920 |
8,312 |
|||
Deferred revenue |
22,797 |
21,021 |
|||
Total current liabilities |
129,151 |
104,912 |
|||
LONG-TERM LIABILITIES |
|||||
Series B Debentures, net of current maturities |
48,985 |
58,850 |
|||
Deferred tax liabilities |
7,094 |
5,082 |
|||
Other long-term liabilities |
7,975 |
8,321 |
|||
Long-term operating lease liabilities |
40,945 |
43,394 |
|||
Accrued severance pay |
6,319 |
6,364 |
|||
Total long-term liabilities |
111,318 |
122,011 |
|||
EQUITY |
227,854 |
225,498 |
|||
TOTAL LIABILITIES AND EQUITY |
468,323 |
452,421 |
SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES |
||
CONSOLIDATED STATEMENT OF CASH FLOW |
||
U.S. dollars in thousands |
||
For the three months ended March 31, |
||
2020 |
2019 |
|
(unaudited) |
(unaudited) |
|
Cash flows from operating activities: |
||
Net income |
6,890 |
5,176 |
Reconciliation of net income to net cash provided by operating |
||
Depreciation and amortization |
5,226 |
4,605 |
Accretion of discount on Series B Debentures |
33 |
39 |
Stock-based compensation related to options issued to employees |
622 |
453 |
Net changes in operating assets and liabilities, net of amount acquired: |
||
Trade receivables, net and unbilled receivables |
(9,009) |
(4,194) |
Deferred tax assets, net |
(1,257) |
(855) |
Other operating assets |
2,260 |
328 |
Trade payables |
(52) |
(426) |
Other operating liabilities |
(759) |
1,247 |
Deferred revenues |
1,655 |
4,167 |
Accrued severance pay, net |
150 |
10 |
Net cash provided by operating activities |
5,759 |
10,550 |
Cash flows from investing activities: |
||
Purchase of property and equipment |
(552) |
(641) |
Investment in deposit |
(665) |
(1,106) |
Proceeds from restricted deposit used for completed acquisition |
22,890 |
- |
Payments for business acquisitions, net of cash acquired |
(22,061) |
- |
Capitalized software development costs |
(1,437) |
(1,392) |
Net cash used in investing activities |
(1,825) |
(3,139) |
Cash flows from financing activities: |
||
Proceeds from employee stock options exercised |
600 |
17 |
Repayment of Series B Debenture |
(9,898) |
(9,898) |
Receipt of short-term loan |
20,000 |
- |
Repayment of loan |
- |
(2) |
Payment of contingent considerations |
(538) |
(58) |
Dividend to non-controlling interest |
- |
(66) |
Net cash used in financing activities |
10,164 |
(10,007) |
Effect of exchange rate changes on cash and cash equivalents |
(836) |
1,352 |
Increase (decrease) in cash and cash equivalents |
13,262 |
(1,244) |
Cash and cash equivalents at the beginning of period |
66,295 |
64,628 |
Cash and cash equivalents at the end of period |
79,557 |
63,384 |
Debentures Covenants
As of March 31, 20120, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:
Covenant 1
- Target shareholders' equity (excluding minority interest): above $120 million.
- Actual shareholders' equity equal to $226 million.
Covenant 2
- Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
- Actual ratio of net financial indebtedness to net capitalization equal to (0.08)%.
Covenant 3
- Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
- Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (0.003).
Logo - http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg
Investors and Media Contact
Brett Mass
Managing Partner
Hayden IR
Phone: +1 646-536-7331
Email: [email protected]
SOURCE Sapiens International Corporation
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article